View drug registration information details.


ItemsRegistration information
ID119
No119
Brand NameFERASIRROX-250 TABLET
IngredientsDEFERASIROX 250 MG
Dosage FormTABLET
Primary PackagingALU-ALU BLISTER
StorageSTORE IN A COOL AND DRY PLACE, PROTECT FORM LIGHT
Shelf Life2 YEARS
Pack SizeBOX OF 1 X 10'S
Dispensing CategoryPrescription only
ATC ClassificationV03AC03
Pharmaceutical ClassIron chelating agents
IndicationsFOR THE TREATMENT OF CHRONIC IRON OVERLOAD DUE TO BLOOD TRANSFUSION (TRANSFUSIONAL HEMOSIDEROSIS) IN PATIENTS 2 YEARS OF AGE AND OLDER.
ContraindicationsCREATININE CLEARANCE < 40 ML/MIN, KNOWN HYPERSENSITIVITY
Side EffectsABDOMINAL PAIN, COUGH, DIARRHEA, HEADACHE, INCREASED SERUM CREATININE, INFLUENZA, NASOPHARYNGITIS, NAUSEA, VOMITING,
Unit Price
EDL No
DescriptionWHITE TO OFF WHITE, OVAL SHAPED DISPERSIBLE TABLETS, HAVING U ENGRAVED ON ONE AND PLAIN ON OTHER SIDE, FREE FROM DIRT, SPOT AND OTHER ANY VISIBLE IMPURITIES
Note
License OwnerCITI TRADE IMPORT-EXPORT SOLE CO.,LTD
ManufacturerUNIMED UNIHEALTH PHARMACEUTICAL LIMITED
CountryBANGLADESH
Import Registration No225-356-045
Import Registration Date28-ธ.ค.-2011
ActivityCERTIFICATE RELEASED
Applied Date14-มิ.ย.-2024
FDD Registration No12 I 5818/24
FDD Registration Date2024-12-16
Expiry Date2029-12-15

Back to drug list